XML 97 R79.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Stock Option Activity (Detail) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Stock Option Shares      
Grants outstanding at beginning of the period 8,806,204 5,436,951 6,515,976
Granted 2,152,439 4,805,722 [1] 1,285,051
Exercised (2,119,306) (792,845) (1,056,821)
Cancelled (448,166) (643,624) (1,307,255)
Grants outstanding at end of the period 8,391,171 8,806,204 5,436,951
Grants exercisable at end of the period 2,304,791 3,288,712 2,942,624
Grants vested and expected to vest at end of the period 6,643,835 6,910,022 5,116,409
Weighted Average Exercise Price      
Grants outstanding at beginning of the period $ 29.74 $ 22.70 $ 23.91
Granted 90.15 35.09 14.89
Exercised 22.89 17.40 18.31
Cancelled 46.11 25.44 24.61
Grants outstanding at end of the period 46.09 29.74 22.70
Grants exercisable at end of the period 27.69 24.76 24.42
Grants vested and expected to vest at end of the period $ 45.43 $ 28.49 $ 22.83
Aggregate Intrinsic Value      
Outstanding at end of year $ 551,131    
Exercisable at end of year 187,693    
Vested and expected to vest $ 433,681    
Weighted Average Remaining Contractual Life (Years)      
Outstanding at end of year 7 years 8 months 12 days    
Exercisable at end of year 5 years 6 months    
Vested and expected to vest 7 years 4 months 24 days    
[1] In June 2017, the Company granted its new CEO 3,300,000 options with service and market conditions. These options have a five-year cliff vesting schedule. The fair value of $13.48 for these options was determined by a lattice model with Monte Carlo simulations. The remaining are service-based options which have a four-year vesting schedule with 25% vesting on the first anniversary and 1/48 monthly thereafter.